Monitor for the closing of the S-4 transaction, which will trigger share issuance and potentially a reverse split or name change. The low market cap and small institutional holdings suggest limited liquidity before the deal closes.
Price Chart
Executive Summary
VYNE Therapeutics' registration statement (S-4, file 333-294804) covering the merger or business combination was declared effective by the SEC on June 15, 2026. The company can now proceed with the transaction, which likely leads to the issuance of shares to target shareholders or debt holders.
Key Facts
- EFFECT notice filed June 17, 2026, for effectiveness date June 15, 2026.
- Registration statement type is S-4, typically used for mergers/business combinations.
- No specific deal terms, sizes, or pricing from the S-4 are available in the documents.
- Company has a market cap of ~$21M and pharmaceutical preparation SIC.
Financial Impact
Effectiveness removes a key regulatory hurdle — no financial figures available in the prompt. Deal value and share issuance terms are not disclosed.
Risk Factors
- Uncertainty around the specific deal terms — no valuation or pricing disclosed.
- Dilution risk for existing common shareholders from shares issued in the business combination.
- Low market cap ~$21M and limited analyst coverage imply higher volatility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002010 |
| Document: 9999999995-26-002010-index.html | 9999999995-26-002010 |
| Document: 9999999995-26-002010.txt | 9999999995-26-002010 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | SC 13G | — | awaiting T+20 | — | — |
Jul 29, 2026 12w ago | 3 | $28.05 | awaiting T+20 | — | — |
Jul 21, 2026 14w ago | 8-K | $0.8927 | awaiting T+20 | — | — |
Jul 14, 2026 15w ago | 425 / 8-K | $0.7110 | awaiting T+20 | — | — |
Jul 10, 2026 15w ago | 425 / 8-K | $0.6376 | awaiting T+20 | — | — |
Jun 17, 2026 18w ago | EFFECT | $0.6311 $0.7675 | ▲ +21.61% | ▲ +20.30% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers